$46.26 0.76 (+1.67%)
11/6/2009 4:00 PM

Gilead Sciences, Inc. (GILD)

CAPS Rating: 5 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Current Price $46.26 Mkt Cap $41.83B
Open $45.49 P/E Ratio 17.11
Prev. Close $45.50 Div. (Yield) N/A (N/A)
Daily Range $45.40 - $46.61 Volume 8,652,250
52-Wk Range $39.37 - $53.28 Avg. Daily Vol. 8,661,000

GILD News and Commentary

View All GILD News and Commentary

Caps

How do you think GILD will perform vs the S&P 500?

Add Stock to Watchlist

All Members

1,702 Outperform
50 Underperform
 

All-Star Members

472 Outperform
13 Underperform
 

Wall Street

30 Outperform
1 Underperform
 

Top GILD Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

corcione (57.84)
Submitted May 11, 2009

Gilead is a leader in HIV treatment and the company also receives royalties from Roche for Tamiflu, a treatment for
influenza. The new US administration is committed to increase spending for HIV diagnosis and treatment.
Generic drug… More

0 Comments | Reply | Report this Post

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

GILD VS S&P 500 (SPY)

Fools bullish on GILD are also bullish on:

Fools bearish on GILD are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about GILD.

Recs

0
Member Avatar 881500 (90.46) Submitted: 11/2/2009 10:03:55 PM : Outperform Start Price: $42.43 GILD Score: +5.76

I like the statistics about this company, a good margin, effective management numbers good roi and roic, i dont see a lot not to like, except that it operates from within the veil of the great OZ (or one of them) the FDA) haha.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar sccoast1700 (< 20) Submitted: 10/30/2009 9:23:55 PM : Outperform Start Price: $42.96 GILD Score: +4.80

A recession proof business. Leader in HIV /Aids treatment.Good products in the works for hypertension, liver fibrosis, and chrohic hepatitis c. Solid balance sheet.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar Bawls (56.21) Submitted: 10/29/2009 3:17:45 PM : Outperform Start Price: $42.82 GILD Score: +7.59

This stock unfortunately gets punished every time it reports strong profits, the recovers......

Report this Post 0 Comments | Reply | Permalink
View All 218 Pitches »

Leaderboard

Find the members with the highest scoring picks in GILD.

Score Leader

TMFPhila

TMFPhila (87.81) Score: +81.68

The Score Leader is the member with the highest score across all their picks in GILD.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
UrineLuck73 < 20 1/29/2007 Outperform NS $31.23 +48.15% -20.03% +68.18
WilliamCrook2003 56.66 1/29/2007 Outperform 1Y $31.23 +48.15% -20.03% +68.18 1 Comment
JSergeant < 20 7/3/2006 Outperform 3Y $29.57 +56.44% -10.44% +66.88
predragj 90.33 1/30/2007 Outperform NS $31.63 +46.28% -20.12% +66.40
mxdfool < 20 12/15/2006 Outperform 5Y $31.77 +45.61% -20.40% +66.00
betsypurcell < 20 1/24/2007 Outperform NS $31.82 +45.40% -20.47% +65.87
opveiby 76.48 1/25/2007 Outperform 5Y $32.06 +44.31% -20.95% +65.26
Redskins2k9 73.47 1/25/2007 Outperform 5Y $32.06 +44.31% -20.95% +65.26
rmarinchek 79.64 1/25/2007 Outperform 3W $32.06 +44.31% -20.95% +65.26
jer8899 69.94 1/23/2007 Outperform NS $31.99 +44.63% -20.46% +65.09
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackWedbush < 20 10/21/2009 Underperform NS $45.27 +2.19% -1.75% -3.94
TrackMorganJos < 20 4/22/2009 Outperform NS $46.23 +0.06% +28.37% -28.31
TrackThinkEquity 69.79 4/14/2009 Outperform NS $47.25 -2.10% +27.30% -29.40
TrackWedbush < 20 3/13/2009 Outperform NS $44.59 +1.53% +46.63% -45.11 10/21/2009 @ $45.27
TrackStanfordRes 80.42 12/23/2008 Outperform NS $50.13 -7.72% +24.56% -32.28
TrackMerriman < 20 12/15/2008 Outperform NS $44.95 +2.91% +23.47% -20.55
TrackNeedham < 20 11/12/2008 Outperform NS $43.90 +5.38% +24.60% -19.22
TrackBofASec 93.50 10/24/2008 Outperform NS $42.81 +8.06% +30.55% -22.49
TrackZacks 69.52 10/20/2008 Outperform 3M $46.49 +2.88% -4.74% +7.62 7/17/2009 @ $47.83 1 Comment
TrackBMOCapital 86.09 10/17/2008 Outperform NS $42.91 +7.81% +17.19% -9.38
TrackRWBaird 85.02 9/12/2008 Outperform NS $49.42 -6.39% -11.08% +4.69
TrackLadenburg 46.65 7/18/2008 Outperform NS $49.81 -7.13% -12.05% +4.92
TrackDeutscheSec 89.50 6/19/2008 Outperform NS $53.17 -13.00% -17.17% +4.18
TrackPacificGrow 90.86 5/21/2008 Outperform NS $52.57 -12.00% -20.46% +8.45
TrackOppenheimer 26.63 4/17/2008 Outperform NS $50.99 -9.28% -18.42% +9.14
TrackJimCramer < 20 4/2/2008 Outperform 3W $51.90 -10.87% -18.78% +7.92
TrackDodgeCox 86.63 3/31/2008 Outperform NS $51.53 -10.23% -15.82% +5.59 1 Comment
TrackJimCramer < 20 3/13/2008 Underperform 3W $48.49 +7.03% +3.90% -3.13 4/3/2008 @ $51.90
TrackWachovia 35.10 1/31/2008 Outperform NS $44.88 +3.07% -16.31% +19.38
TrackFBRCapitalM 75.98 1/24/2008 Outperform NS $45.92 +15.31% -5.04% +20.35 6/30/2008 @ $52.95
TrackCreditSuiss 91.16 1/7/2008 Outperform NS $46.83 -1.22% -21.22% +20.00
TrackEdwardOwens 98.26 9/30/2007 Outperform NS $40.87 +13.19% -26.44% +39.63 7 Comments
TrackBMOCapital 86.09 9/28/2007 Outperform NS $40.88 +25.73% -17.80% +43.53 7/18/2008 @ $51.40
TrackJimJubak 76.01 9/25/2007 Outperform 1Y $40.72 +13.61% -25.86% +39.47
TrackZacks 69.52 6/11/2007 Outperform 3M $39.61 +10.12% -9.23% +19.36 2/25/2008 @ $43.62 1 Comment
TrackJimCramer < 20 5/18/2007 Outperform 3W $41.51 +16.82% -13.74% +30.56 3/14/2008 @ $48.49
TrackLeerinkSwan 84.26 4/19/2007 Outperform NS $39.49 +17.14% -22.74% +39.88
TrackJimCramer < 20 4/5/2007 Underperform 3W $39.16 +6.00% +5.81% -0.19 5/19/2007 @ $41.51
TrackUBS 86.41 2/21/2007 Outperform NS $36.50 +26.74% -21.91% +48.65
TrackJefferies 75.83 2/21/2007 Outperform NS $36.50 +40.82% -13.96% +54.78 7/18/2008 @ $51.40
TrackDeutscheSec 89.50 2/2/2007 Outperform NS $35.50 +15.04% +5.60% +9.45 6/6/2007 @ $40.84
TrackPZK < 20 2/2/2007 Outperform NS $35.50 +30.31% -21.43% +51.74
TrackStifel 94.70 2/1/2007 Outperform NS $34.95 +32.36% -21.12% +53.48
TrackJMP < 20 2/1/2007 Outperform NS $34.95 +32.36% -21.12% +53.48
TrackBofASec 93.50 2/1/2007 Outperform NS $34.92 +47.05% -9.91% +56.96 9/2/2008 @ $51.35
TrackCarisandCo 78.62 12/21/2006 Outperform NS $32.49 +49.25% -7.46% +56.71 3/13/2008 @ $48.49
TrackBroadpoint.AmTech 73.02 12/19/2006 Outperform NS $31.86 +45.20% -19.60% +64.80
TrackRodmanRen < 20 12/4/2006 Outperform NS $32.90 +40.61% -18.93% +59.53
TrackLazardCapit < 20 11/22/2006 Outperform NS $33.80 +36.86% -19.27% +56.14
TrackLehmanBros 76.60 10/19/2006 Outperform NS $33.98 +55.41% -5.17% +60.58 8/28/2008 @ $52.81
TrackCreditSuiss 91.16 9/28/2006 Outperform NS $33.72 +21.10% +14.18% +6.91 6/6/2007 @ $40.84
TrackRBCCapMkts 81.74 9/27/2006 Outperform NS $33.44 +38.32% -14.77% +53.09
TrackMontgomery < 20 8/16/2006 Outperform NS $31.30 +47.82% -10.73% +58.55
TrackJimCramer < 20 3/8/2006 Outperform 3W $30.39 +28.86% +12.72% +16.13 4/5/2007 @ $39.16

Featured Broker Partners